These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 11684570)

  • 1. Creatinine production and excretion in end-stage renal disease.
    Blake PG; Chu KH
    Am J Kidney Dis; 2001 Nov; 38(5):1119-21. PubMed ID: 11684570
    [No Abstract]   [Full Text] [Related]  

  • 2. Peritoneal clearance of inorganic sulfate.
    Uribarri J; Buquing J; Dimaano F; Marcus RG
    Clin Nephrol; 1995 Jul; 44(1):56-9. PubMed ID: 7554534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peritoneal equilibration test.
    Peritoneal Dialysis Special Interest Group
    Nephrol Nurs J; 2005; 32(4):452-3. PubMed ID: 16180789
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peritoneal equilibration test].
    Morduchowicz G; Feldman T; van Dyk DJ; Boner G
    Harefuah; 1990 Mar; 118(6):312-5. PubMed ID: 2347531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lean body mass by Dual Energy X-ray Absorptiometry (DEXA) and by urine and dialysate creatinine recovery in CAPD and pre-dialysis patients compared to normal subjects.
    Nielsen PK; Ladefoged J; Olgaard K
    Adv Perit Dial; 1994; 10():99-103. PubMed ID: 7999874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chyloperitoneum in a peritoneal dialysis patient.
    Levy RI; Wenk RE
    Am J Kidney Dis; 2001 Sep; 38(3):E12. PubMed ID: 11532714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adequacy of solute and water removal in children treated with nightly intermittent peritoneal dialysis.
    Edefonti A; Picca M; Ghio L; Bassi S; Cattarelli D; Leccese V
    Adv Perit Dial; 1992; 8():402-5. PubMed ID: 1361833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Na concentration solution for CAPD.
    Nakayama M; Hasegawa T; Kubo H; Yamamoto H; Shigematsu T; Kawaguchi Y; Sakai O
    Clin Nephrol; 1996 Jan; 45(1):66-8. PubMed ID: 8616961
    [No Abstract]   [Full Text] [Related]  

  • 9. High creatinine excretion ratio predicts a good outcome in peritoneal dialysis patients.
    Perez RA; Blake PG; Spanner E; Patel M; McMurray S; Heidenheim P; Lindsay RM
    Am J Kidney Dis; 2000 Aug; 36(2):362-7. PubMed ID: 10922315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatinine excretion in continuous peritoneal dialysis: a systematic error of the Cockroft-Gault formula.
    Tzamaloukas AH; Murata GH
    Am J Kidney Dis; 2001 Oct; 38(4):862-6. PubMed ID: 11576892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between phosphorus and creatinine clearance in peritoneal dialysis: clinical implications.
    Sedlacek M; Dimaano F; Uribarri J
    Am J Kidney Dis; 2000 Nov; 36(5):1020-4. PubMed ID: 11054360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous ambulatory peritoneal dialysis best treatment for end-stage renal disease.
    Moncrief JW; Popovich RP
    Kidney Int Suppl; 1985 Dec; 17():S23-5. PubMed ID: 3867796
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
    Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
    Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clearance of urea, creatinine, beta 2 microglobulin and the loss of proteins in treatment with continuous ambulatory peritoneal dialysis].
    Kozjak D; Prejac M; Jeren-Struić B; Gudelj J; Kovarbasić B
    Lijec Vjesn; 1982; 104(11-12):532-5. PubMed ID: 6764943
    [No Abstract]   [Full Text] [Related]  

  • 17. Cimetidine clearance during intermittent and chronic peritoneal dialysis.
    Hyneck ML; Murphy JF; Lipschutz DE
    Am J Hosp Pharm; 1981 Nov; 38(11):1760-2. PubMed ID: 7304634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of osteocalcin in adults with end-stage renal disease undergoing CAPD.
    Klein JR; Grunewald RW; Steffgen J; Franz HE
    Adv Perit Dial; 1991; 7():225-9. PubMed ID: 1680431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of CAPD and PD-plus effectiveness.
    Iles-Smith H; Curwell J; Gokal R
    EDTNA ERCA J; 1999; 25(3):27-9. PubMed ID: 10786491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous ambulatory peritoneal dialysis in end-stage renal disease.
    Chaimovitz C; Zimlichman R; Zlotnik M
    Isr J Med Sci; 1983 Jun; 19(6):575-6. PubMed ID: 6862870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.